 |
|
Necessity of induction agent modification for old age kidney transplant recipients
Kyeong Deok Kim, Kyo Won Lee, Jae Berm Park, Woo Sung Sim, Manuel Lim, Eun Sung Jeong, Jieun Kwon, Jaehun Yang
Kidney Res Clin Pract. 2025;44(2):349-360. Published online 2023 Nov 1 DOI: https://doi.org/10.23876/j.krcp.23.068
|
|
Citations to this article as recorded by
 Alemtuzumab Associated With Higher Mortality Than Basiliximab in Older Kidney Transplant Recipients
Michelle Guo, Vinayak Rohan, Daniela Ladner, John Friedewald, Joshua Cahan, Zachary Dietch
Journal of Surgical Research.2025; 305: 197. CrossRef Increased risk of genitourinary cancer in kidney transplant recipients: a large-scale national cohort study and its clinical implications
Hyunho Kim, Kyung-Hee Chae, Arum Choi, Mi-hyeong Kim, Ji Hyung Hong, Bum Soon Choi, Sukil Kim, Tae Hyun Ban
International Urology and Nephrology.2024; 57(3): 715. CrossRef
|